"What about Palo Alto which has increased their holdings in the latest report. I have met them including one MD on the staff who is high on MNTA. They struck me as being as good as any biotech investors I have met. (Present company excluded of course.)" -Were these the guys sitting in on the patent trial who were high on it in the 20s?
Market Data 
Markets 
AI
